目次

Table of Contents

1 Introduction
1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions

2 Top 5 Emerging Countries Generics
2.1. Industry Outlook

3 Generics in South Africa
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis

4 Macroeconomic Indicators
4.1. Country data

5 Generics in Brazil
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis

6 Macroeconomic Indicators
6.1. Country data

7 Generics in China
7.1. Market Overview
7.2. Market Data
7.3. Market Segmentation
7.4. Market outlook
7.5. Five forces analysis

8 Macroeconomic Indicators
8.1. Country data

9 Generics in India
9.1. Market Overview
9.2. Market Data
9.3. Market Segmentation
9.4. Market outlook
9.5. Five forces analysis

10 Macroeconomic Indicators
10.1. Country data

11 Generics in Mexico
11.1. Market Overview
11.2. Market Data
11.3. Market Segmentation
11.4. Market outlook
11.5. Five forces analysis

12 Macroeconomic Indicators
12.1. Country data

13 Company Profiles
13.1. Aspen Pharmacare Holdings Ltd
13.2. Teva Pharmaceutical Industries Limited
13.3. Adcock Ingram Holdings Ltd
13.4. Novartis AG
13.5. Sanofi SA
13.6. EMS SA
13.7. Ache Laboratorios Farmaceuticos SA
13.8. Eurofarma Laboratorios SA
13.9. Viatris Inc.
13.10. Pfizer Inc.
13.11. Grand Pharmaceutical Group Limited
13.12. Lupin Ltd
13.13. Cipla Limited
13.14. Sun Pharmaceutical Industries Ltd
13.15. Aurobindo Pharma Ltd

14 Appendix
14.1. Methodology
14.2. About MarketLine

List of Tables
Table 1: Top 5 emerging countries generics industry, revenue ($m), 2018-27
Table 2: Top 5 emerging countries generics industry, revenue ($m), 2018-22
Table 3: Top 5 emerging countries generics industry forecast, revenue ($m), 2022-27
Table 4: South Africa generics market value: $ million, 2017-22
Table 5: South Africa generics market volume: %, 2017-22
Table 6: South Africa generics market geography segmentation: $ million, 2022
Table 7: South Africa generics market value forecast: $ million, 2022-27
Table 8: South Africa generics market volume forecast: %, 2022-27
Table 9: South Africa size of population (million), 2018-22
Table 10: South Africa gdp (constant 2005 prices, $ billion), 2018-22
Table 11: South Africa gdp (current prices, $ billion), 2018-22
Table 12: South Africa inflation, 2018-22
Table 13: South Africa consumer price index (absolute), 2018-22
Table 14: South Africa exchange rate, 2018-22
Table 15: Brazil generics market value: $ million, 2017-22
Table 16: Brazil generics market volume: %, 2017-22
Table 17: Brazil generics market geography segmentation: $ million, 2022
Table 18: Brazil generics market value forecast: $ million, 2022-27
Table 19: Brazil generics market volume forecast: %, 2022-27
Table 20: Brazil size of population (million), 2018-22
Table 21: Brazil gdp (constant 2005 prices, $ billion), 2018-22
Table 22: Brazil gdp (current prices, $ billion), 2018-22
Table 23: Brazil inflation, 2018-22
Table 24: Brazil consumer price index (absolute), 2018-22
Table 25: Brazil exchange rate, 2018-22
Table 26: China generics market value: $ million, 2017-22
Table 27: China generics market volume: %, 2017-22
Table 28: China generics market geography segmentation: $ million, 2022
Table 29: China generics market value forecast: $ million, 2022-27
Table 30: China generics market volume forecast: %, 2022-27
Table 31: China size of population (million), 2018-22
Table 32: China gdp (constant 2005 prices, $ billion), 2018-22
Table 33: China gdp (current prices, $ billion), 2018-22
Table 34: China inflation, 2018-22
Table 35: China consumer price index (absolute), 2018-22
Table 36: China exchange rate, 2018-22
Table 37: India generics market value: $ million, 2017-22
Table 38: India generics market volume: %, 2017-22
Table 39: India generics market geography segmentation: $ million, 2022
Table 40: India generics market value forecast: $ million, 2022-27
Table 41: India generics market volume forecast: %, 2022-27
Table 42: India size of population (million), 2018-22
Table 43: India gdp (constant 2005 prices, $ billion), 2018-22
Table 44: India gdp (current prices, $ billion), 2018-22
Table 45: India inflation, 2018-22
Table 46: India consumer price index (absolute), 2018-22
Table 47: India exchange rate, 2018-22
Table 48: Mexico generics market value: $ million, 2017-22
Table 49: Mexico generics market volume: %, 2017-22
Table 50: Mexico generics market geography segmentation: $ million, 2022
Table 51: Mexico generics market value forecast: $ million, 2022-27
Table 52: Mexico generics market volume forecast: %, 2022-27
Table 53: Mexico size of population (million), 2018-22
Table 54: Mexico gdp (constant 2005 prices, $ billion), 2018-22
Table 55: Mexico gdp (current prices, $ billion), 2018-22
Table 56: Mexico inflation, 2018-22
Table 57: Mexico consumer price index (absolute), 2018-22
Table 58: Mexico exchange rate, 2018-22
Table 59: Aspen Pharmacare Holdings Ltd: key facts
Table 60: Aspen Pharmacare Holdings Ltd: Annual Financial Ratios
Table 61: Aspen Pharmacare Holdings Ltd: Key Employees
Table 62: Teva Pharmaceutical Industries Limited: key facts
Table 63: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
Table 64: Teva Pharmaceutical Industries Limited: Key Employees
Table 65: Adcock Ingram Holdings Ltd: key facts
Table 66: Adcock Ingram Holdings Ltd: Annual Financial Ratios
Table 67: Adcock Ingram Holdings Ltd: Key Employees
Table 68: Novartis AG: key facts
Table 69: Novartis AG: Annual Financial Ratios
Table 70: Novartis AG: Key Employees
Table 71: Novartis AG: Key Employees Continued
Table 72: Sanofi SA: key facts
Table 73: Sanofi SA: Annual Financial Ratios
Table 74: Sanofi SA: Key Employees
Table 75: Sanofi SA: Key Employees Continued
Table 76: EMS SA: key facts
Table 77: EMS SA: Key Employees
Table 78: Ache Laboratorios Farmaceuticos SA: key facts
Table 79: Ache Laboratorios Farmaceuticos SA: Key Employees
Table 80: Eurofarma Laboratorios SA: key facts
Table 81: Eurofarma Laboratorios SA: Key Employees
Table 82: Viatris Inc.: key facts
Table 83: Viatris Inc.: Annual Financial Ratios
Table 84: Viatris Inc.: Key Employees
Table 85: Viatris Inc.: Key Employees Continued
Table 86: Pfizer Inc.: key facts
Table 87: Pfizer Inc.: Annual Financial Ratios
Table 88: Pfizer Inc.: Key Employees
Table 89: Pfizer Inc.: Key Employees Continued
Table 90: Grand Pharmaceutical Group Limited: key facts
Table 91: Grand Pharmaceutical Group Limited: Annual Financial Ratios
Table 92: Grand Pharmaceutical Group Limited: Key Employees
Table 93: Lupin Ltd: key facts
Table 94: Lupin Ltd: Annual Financial Ratios
Table 95: Lupin Ltd: Key Employees
Table 96: Cipla Limited: key facts
Table 97: Cipla Limited: Annual Financial Ratios
Table 98: Cipla Limited: Key Employees
Table 99: Sun Pharmaceutical Industries Ltd: key facts
Table 100: Sun Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 101: Sun Pharmaceutical Industries Ltd: Key Employees
Table 102: Aurobindo Pharma Ltd: key facts
Table 103: Aurobindo Pharma Ltd: Annual Financial Ratios
Table 104: Aurobindo Pharma Ltd: Key Employees

List of Figures
Figure 1: Top 5 emerging countries generics industry, revenue ($m), 2018-27
Figure 2: Top 5 emerging countries generics industry, revenue ($m), 2018-22
Figure 3: Top 5 emerging countries generics industry forecast, revenue ($m), 2022-27
Figure 4: South Africa generics market value: $ million, 2017-22
Figure 5: South Africa generics market volume: %, 2017-22
Figure 6: South Africa generics market geography segmentation: % share, by value, 2022
Figure 7: South Africa generics market value forecast: $ million, 2022-27
Figure 8: South Africa generics market volume forecast: %, 2022-27
Figure 9: Forces driving competition in the generics market in South Africa, 2022
Figure 10: Drivers of buyer power in the generics market in South Africa, 2022
Figure 11: Drivers of supplier power in the generics market in South Africa, 2022
Figure 12: Factors influencing the likelihood of new entrants in the generics market in South Africa, 2022
Figure 13: Factors influencing the threat of substitutes in the generics market in South Africa, 2022
Figure 14: Drivers of degree of rivalry in the generics market in South Africa, 2022
Figure 15: Brazil generics market value: $ million, 2017-22
Figure 16: Brazil generics market volume: %, 2017-22
Figure 17: Brazil generics market geography segmentation: % share, by value, 2022
Figure 18: Brazil generics market value forecast: $ million, 2022-27
Figure 19: Brazil generics market volume forecast: %, 2022-27
Figure 20: Forces driving competition in the generics market in Brazil, 2022
Figure 21: Drivers of buyer power in the generics market in Brazil, 2022
Figure 22: Drivers of supplier power in the generics market in Brazil, 2022
Figure 23: Factors influencing the likelihood of new entrants in the generics market in Brazil, 2022
Figure 24: Factors influencing the threat of substitutes in the generics market in Brazil, 2022
Figure 25: Drivers of degree of rivalry in the generics market in Brazil, 2022
Figure 26: China generics market value: $ million, 2017-22
Figure 27: China generics market volume: %, 2017-22
Figure 28: China generics market geography segmentation: % share, by value, 2022
Figure 29: China generics market value forecast: $ million, 2022-27
Figure 30: China generics market volume forecast: %, 2022-27
Figure 31: Forces driving competition in the generics market in China, 2022
Figure 32: Drivers of buyer power in the generics market in China, 2022
Figure 33: Drivers of supplier power in the generics market in China, 2022
Figure 34: Factors influencing the likelihood of new entrants in the generics market in China, 2022
Figure 35: Factors influencing the threat of substitutes in the generics market in China, 2022
Figure 36: Drivers of degree of rivalry in the generics market in China, 2022
Figure 37: India generics market value: $ million, 2017-22
Figure 38: India generics market volume: %, 2017-22
Figure 39: India generics market geography segmentation: % share, by value, 2022
Figure 40: India generics market value forecast: $ million, 2022-27
Figure 41: India generics market volume forecast: %, 2022-27
Figure 42: Forces driving competition in the generics market in India, 2022
Figure 43: Drivers of buyer power in the generics market in India, 2022
Figure 44: Drivers of supplier power in the generics market in India, 2022
Figure 45: Factors influencing the likelihood of new entrants in the generics market in India, 2022
Figure 46: Factors influencing the threat of substitutes in the generics market in India, 2022
Figure 47: Drivers of degree of rivalry in the generics market in India, 2022
Figure 48: Mexico generics market value: $ million, 2017-22
Figure 49: Mexico generics market volume: %, 2017-22
Figure 50: Mexico generics market geography segmentation: % share, by value, 2022
Figure 51: Mexico generics market value forecast: $ million, 2022-27
Figure 52: Mexico generics market volume forecast: %, 2022-27
Figure 53: Forces driving competition in the generics market in Mexico, 2022
Figure 54: Drivers of buyer power in the generics market in Mexico, 2022
Figure 55: Drivers of supplier power in the generics market in Mexico, 2022
Figure 56: Factors influencing the likelihood of new entrants in the generics market in Mexico, 2022
Figure 57: Factors influencing the threat of substitutes in the generics market in Mexico, 2022
Figure 58: Drivers of degree of rivalry in the generics market in Mexico, 2022